Stock comparison
ILLUMINA, INC. is 3.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($29.32 B vs $8.09 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ILMN is larger
ILLUMINA, INC. is 3.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($29.32 B vs $8.09 B).
Market value leader
ILMN
ILLUMINA, INC. is 3.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($29.32 B vs $8.09 B).
Revenue leader
ILMN
BIO: $2.58B vs ILMN: $4.34B.
Profit leader
ILMN
BIO: $759.90M vs ILMN: $850.00M.
Margin leader
BIO
BIO: 29.4% vs ILMN: 19.6% net margin.
| Metric | BIO | ILMN |
|---|---|---|
| Market cap | $8.09 B | $29.32 B |
| US-listed rank | #1080 | #478 |
| Revenue (latest FY) | $2.58B | $4.34B |
| Net income (latest FY) | $759.90M | $850.00M |
| Net margin | 29.4% | 19.6% |
| P/E (trailing FY) | 10.6x | 34.5x |
| SEC filings | 1,494 | 3,713 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ILLUMINA, INC. is 3.6x more valuable than Bio-Rad Laboratories, Inc. by market capitalization ($29.32 B vs $8.09 B).
In their latest fiscal years, Bio-Rad Laboratories, Inc. reported $2.58B in revenue while ILLUMINA, INC. reported $4.34B.
Full pages: Bio-Rad Laboratories, Inc. and ILLUMINA, INC., or browse the full rankings.